UK Presents New Licensing Pathway For Innovative Drugs
MHRA To Be ‘Enabling Regulator’
A “powerful new vision” for the post-Brexit UK regulatory framework was unveiled at a conference organized by the BioIndustry Association and the medicines regulator, the MHRA.
